Concern raised over shortage of female gastroenterologists
KARACHI: A severe shortage of trained and qualified female gastroenterologists in Pakistan is contributing to delayed diagnoses and poor health outcomes for women suffering from gastrointestinal and liver diseases, as many are reluctant to consult male doctors due to cultural and social barriers.
This concern was raised on the second day of the 7th Annual Conference of the Pakistan GI and Liver Disease Society (PGLDS), where experts warned that women across rural and urban areas are silently enduring serious health issues that are often diagnosed too late for effective treatment.
They called for a national colorectal cancer screening program, especially for women, who due to the sensitivities involved and lack of female doctors, frequently present in advanced stages when treatment becomes more difficult.
Speaking at the conference here at Liaquat National Hospital's convention centre, local and international specialists called for urgent public health reforms, including screening programs, dietary awareness, and structural changes in homes and schools to prevent a looming health crisis.
Dr Lubna Kamani, President of PGLDS, reiterated the call for early detection and lifestyle change. 'We are facing a tsunami of fatty liver, hepatitis C, and colorectal cancer. It's time people took screening seriously. Medicines for Hepatitis B and C are available in Pakistan, but most people do not know they are infected. We urge everyone to get tested and follow medical advice.'
Without national programs for screening and chronic illness prevention, she warned, the health system will collapse under the weight of non-communicable diseases.
Dr Nazish Butt, a senior member of PGLDS, emphasised the rising burden of obesity and gut health issues in women. She noted that poor diets, sedentary routines, and hormonal factors were making women more vulnerable to gastrointestinal and liver disorders. 'We are seeing more young women with advanced liver disease and GI cancers because they delay seeking help.'
Dr Sajjad Jamil, Secretary General of PGLDS, blamed obesity as the 'mother of all illnesses' and criticised the country's deteriorating dietary culture. 'Children start consuming sugary drinks, processed meat and junk food from an early age. There's no physical activity in schools, no playgrounds, and too much screen time. We are nurturing disease.'
He demanded immediate implementation of a national colorectal cancer screening program and school-based awareness campaigns promoting healthy eating and exercise.
International experts highlighted the importance of preventive approaches. South Korean expert Prof Eun Young Kim shared how her country controls liver and GI diseases through regular screenings, national health insurance, and diet and activity awareness. 'What we see here is preventable. Governments must invest in health promotion, not just treatment.'
Dr Shahid Ahmed, Patron of PGLDS, said the conference aimed to equip local healthcare professionals with updated knowledge and treatment options. 'We've invited experts from South Korea, Turkey, South Africa and beyond to present and train our young doctors on how the world is addressing these diseases.'
Copyright Business Recorder, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
6 hours ago
- Business Recorder
Concern raised over shortage of female gastroenterologists
KARACHI: A severe shortage of trained and qualified female gastroenterologists in Pakistan is contributing to delayed diagnoses and poor health outcomes for women suffering from gastrointestinal and liver diseases, as many are reluctant to consult male doctors due to cultural and social barriers. This concern was raised on the second day of the 7th Annual Conference of the Pakistan GI and Liver Disease Society (PGLDS), where experts warned that women across rural and urban areas are silently enduring serious health issues that are often diagnosed too late for effective treatment. They called for a national colorectal cancer screening program, especially for women, who due to the sensitivities involved and lack of female doctors, frequently present in advanced stages when treatment becomes more difficult. Speaking at the conference here at Liaquat National Hospital's convention centre, local and international specialists called for urgent public health reforms, including screening programs, dietary awareness, and structural changes in homes and schools to prevent a looming health crisis. Dr Lubna Kamani, President of PGLDS, reiterated the call for early detection and lifestyle change. 'We are facing a tsunami of fatty liver, hepatitis C, and colorectal cancer. It's time people took screening seriously. Medicines for Hepatitis B and C are available in Pakistan, but most people do not know they are infected. We urge everyone to get tested and follow medical advice.' Without national programs for screening and chronic illness prevention, she warned, the health system will collapse under the weight of non-communicable diseases. Dr Nazish Butt, a senior member of PGLDS, emphasised the rising burden of obesity and gut health issues in women. She noted that poor diets, sedentary routines, and hormonal factors were making women more vulnerable to gastrointestinal and liver disorders. 'We are seeing more young women with advanced liver disease and GI cancers because they delay seeking help.' Dr Sajjad Jamil, Secretary General of PGLDS, blamed obesity as the 'mother of all illnesses' and criticised the country's deteriorating dietary culture. 'Children start consuming sugary drinks, processed meat and junk food from an early age. There's no physical activity in schools, no playgrounds, and too much screen time. We are nurturing disease.' He demanded immediate implementation of a national colorectal cancer screening program and school-based awareness campaigns promoting healthy eating and exercise. International experts highlighted the importance of preventive approaches. South Korean expert Prof Eun Young Kim shared how her country controls liver and GI diseases through regular screenings, national health insurance, and diet and activity awareness. 'What we see here is preventable. Governments must invest in health promotion, not just treatment.' Dr Shahid Ahmed, Patron of PGLDS, said the conference aimed to equip local healthcare professionals with updated knowledge and treatment options. 'We've invited experts from South Korea, Turkey, South Africa and beyond to present and train our young doctors on how the world is addressing these diseases.' Copyright Business Recorder, 2025
Business Recorder
a day ago
- Business Recorder
Experts warn obesity resulting in many diseases
KARACHI: Calling obesity a full-blown epidemic that has engulfed Pakistan in recent years, leading gastroenterologists and liver specialists have warned that excess body weight is now the leading cause of fatty liver disease, liver failure, and a major reason for the rising demand for liver transplants in the country. Urging people to adopt healthy eating habits and become physically active to avoid premature deaths and costly medical interventions, experts also warned that unhealthy lifestyles and obesity are contributing to an alarming rise in colorectal cancer cases among the relatively young population in Pakistan. They were speaking at the inauguration ceremony of the 7th Annual Conference of the Pakistan GI and Liver Disease Society (PGLDS) at a local hotel, which brought together local and international experts despite ongoing global unrest. Dr Lubna Kamani, President of PGLDS, stressed that obesity is now deeply intertwined with fatty liver disease and a wide range of gastrointestinal (GI) conditions. 'While we now have new medications available for obesity and fatty liver, prevention is still the best strategy. We must eat less but healthy and stay physically active,' she said, while also pointing to a sharp increase in colorectal cancer among young adults, which she linked to unhealthy dietary habits and sedentary lifestyles. 'We need to immediately launch a national colorectal screening program in Pakistan before this silent threat claims more lives.' Addressing the gathering as chief guest, Sindh Health Secretary Rehan Iqbal Baloch welcomed delegates from across the country and acknowledged the serious challenges patients face in accessing GI and liver care. Copyright Business Recorder, 2025
Business Recorder
07-06-2025
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
